Literature DB >> 1691142

Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease.

T Oda1, Y Kojima, T Akaike, S Ijiri, A Molla, H Maeda.   

Abstract

The effects of the 56-kilodalton protease (56K protease) from Serratia marcescens on complement-derived chemotactic activity were examined. Fresh human serum was incubated with zymosan to produce C5a. This activated serum was then incubated with various concentrations of 56K protease, and the chemotactic activity of mouse peritoneal exudate polymorphonuclear leukocytes (PMN) and macrophages was evaluated. A significant dose-dependent decrease of chemotactic activity was observed after protease treatment. Furthermore, treatment of human recombinant C5a with 56K protease at a dose of 1.0 microgram/ml resulted in a complete loss of chemotactic activity. When the living bacteria of the virulent strain, which produced about 10 times more protease than did the less virulent strain, were injected intraperitoneally into mice, the magnitude of infiltration of polymorphonuclear leukocytes into the peritoneal cavity was much lower than that caused by the less virulent strain. Because complement-dependent chemotactic activity is an initial response to bacterial infection, these results suggest indirect pathogenic functions of serratial proteases that suppress chemotactic activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691142      PMCID: PMC258619          DOI: 10.1128/iai.58.5.1269-1272.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture.

Authors:  A Molla; K Matsumoto; I Oyamada; T Katsuki; H Maeda
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

2.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease.

Authors:  K Matsumoto; T Yamamoto; R Kamata; H Maeda
Journal:  J Biochem       Date:  1984-09       Impact factor: 3.387

4.  Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958.

Authors:  K Matsumoto; H Maeda; K Takata; R Kamata; R Okamura
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

5.  The chemical mediation of delayed hypersensitivity skin reactions: III. Purification and characterization of a precursor protein for macrophage-chemotactic factor in normal guinea pig plasma.

Authors:  K Ueda; T Kawaguchi; T Okamoto; T Kambara
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

6.  Pathogenic potentials of bacterial proteases.

Authors:  H Maeda; A Molla
Journal:  Clin Chim Acta       Date:  1989-12-15       Impact factor: 3.786

7.  Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin.

Authors:  M J Imber; S V Pizzo
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

8.  The serratial 56K protease as a major pathogenic factor in serratial keratitis. Clinical and experimental study.

Authors:  R Kamata; K Matsumoto; R Okamura; T Yamamoto; H Maeda
Journal:  Ophthalmology       Date:  1985-10       Impact factor: 12.079

9.  Importance of serratia protease in the pathogenesis of experimental Serratia marcescens pneumonia.

Authors:  D M Lyerly; A S Kreger
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease.

Authors:  D Lyerly; L Gray; A Kreger
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

View more
  14 in total

1.  EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5.

Authors:  Dorothea Orth; Silvia Ehrlenbach; Jens Brockmeyer; Abdul Basit Khan; Georg Huber; Helge Karch; Bettina Sarg; Herbert Lindner; Reinhard Würzner
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 2.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

Review 3.  Bacterial extracellular zinc-containing metalloproteases.

Authors:  C C Häse; R A Finkelstein
Journal:  Microbiol Rev       Date:  1993-12

Review 4.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Molecular characterization of protease activity in Serratia sp. strain SCBI and its importance in cytotoxicity and virulence.

Authors:  Lauren M Petersen; Louis S Tisa
Journal:  J Bacteriol       Date:  2014-09-02       Impact factor: 3.490

7.  Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist.

Authors:  K Maruo; T Akaike; T Ono; H Maeda
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of complement, bradykinin, and inducible cyclooxygenase-2.

Authors:  M Ogino; M Majima; M Kawamura; K Hatanaka; M Saito; Y Harada; M Katori
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

9.  Nitric oxide as an endogenous mutagen for Sendai virus without antiviral activity.

Authors:  Jun Yoshitake; Takaaki Akaike; Teruo Akuta; Fumio Tamura; Tsutomu Ogura; Hiroyasu Esumi; Hiroshi Maeda
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Therapeutic intervention with chicken egg white ovomacroglobulin and a new quinolone on experimental Pseudomonas keratitis.

Authors:  S Miyagawa; R Kamata; K Matsumoto; R Okamura; H Maeda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.